206 related articles for article (PubMed ID: 38142147)
1. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy.
Pan S; Fan R; Han B; Tong A; Guo G
Trends Immunol; 2024 Jan; 45(1):20-31. PubMed ID: 38142147
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-like nanomedicine for cancer immunotherapy.
Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
[TBL] [Abstract][Full Text] [Related]
3. Biomaterials for vaccine-based cancer immunotherapy.
Zhang R; Billingsley MM; Mitchell MJ
J Control Release; 2018 Dec; 292():256-276. PubMed ID: 30312721
[TBL] [Abstract][Full Text] [Related]
4. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
5. Advances and prospects of mRNA vaccines in cancer immunotherapy.
Liu Y; Yan Q; Zeng Z; Fan C; Xiong W
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189068. PubMed ID: 38171406
[TBL] [Abstract][Full Text] [Related]
6. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
7. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine.
Parums DV
Med Sci Monit; 2021 May; 27():e933088. PubMed ID: 33994538
[TBL] [Abstract][Full Text] [Related]
8. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy.
Song H; Su Q; Nie Y; Zhang C; Huang P; Shi S; Liu Q; Wang W
Acta Biomater; 2023 Mar; 158():535-546. PubMed ID: 36632876
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy and nanomedicine.
Sheng WY; Huang L
Pharm Res; 2011 Feb; 28(2):200-14. PubMed ID: 20821040
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccine in cancer therapy: Current advance and future outlook.
Li Y; Wang M; Peng X; Yang Y; Chen Q; Liu J; She Q; Tan J; Lou C; Liao Z; Li X
Clin Transl Med; 2023 Aug; 13(8):e1384. PubMed ID: 37612832
[TBL] [Abstract][Full Text] [Related]
13. mRNA vaccine for cancer immunotherapy.
Miao L; Zhang Y; Huang L
Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
[TBL] [Abstract][Full Text] [Related]
14. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
Front Immunol; 2022; 13():923647. PubMed ID: 35711457
[TBL] [Abstract][Full Text] [Related]
15. Improving Cancer Vaccine Efficiency by Nanomedicine.
Cai J; Wang H; Wang D; Li Y
Adv Biosyst; 2019 Mar; 3(3):e1800287. PubMed ID: 32627400
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy from biology to nanomedicine.
Abdelbaky SB; Ibrahim MT; Samy H; Mohamed M; Mohamed H; Mustafa M; Abdelaziz MM; Forrest ML; Khalil IA
J Control Release; 2021 Aug; 336():410-432. PubMed ID: 34171445
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy.
Hashemi V; Farhadi S; Ghasemi Chaleshtari M; Seashore-Ludlow B; Masjedi A; Hojjat-Farsangi M; Namdar A; Ajjoolabady A; Mohammadi H; Ghalamfarsa G; Jadidi-Niaragh F
Int Immunopharmacol; 2020 Jun; 83():106446. PubMed ID: 32244048
[TBL] [Abstract][Full Text] [Related]
18. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle delivery systems in cancer vaccines.
Krishnamachari Y; Geary SM; Lemke CD; Salem AK
Pharm Res; 2011 Feb; 28(2):215-36. PubMed ID: 20721603
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for advanced cancer immunotherapy.
Diep YN; Kim TJ; Cho H; Lee LP
J Control Release; 2022 Nov; 351():1017-1037. PubMed ID: 36220487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
